data_1kv4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kv4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CA ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.562 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 HG22 ' A' ' 22' ' ' ILE . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.553 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 27' ' ' THR . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 13' ' ' LYS . 17.1 mmtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' CD ' ' C ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' ' CG ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 20' ' ' ARG . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.489 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.577 ' NE ' ' N ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.577 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 27' ' ' THR . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' N ' ' CG ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.579 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 19' ' ' LEU . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.579 ' ND2' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.554 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.547 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 5.3 t80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.49 ' CD ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 28' ' ' ALA . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.576 ' ND2' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 4.6 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 3.9 mmmp? . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' NE ' ' N ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.582 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' N ' HD13 ' A' ' 19' ' ' LEU . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.556 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.496 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 13.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD13 ' HD3' ' A' ' 20' ' ' ARG . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HD3' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.568 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.521 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.521 HG23 ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' HG21 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 28' ' ' ALA . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.486 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.55 HD13 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 31' ' ' VAL . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 27' ' ' THR . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' CD ' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.532 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 3' ' ' ILE . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -56.27 82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 1.8 tt -173.64 58.77 0.22 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.367 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 64.3 Cg_endo -93.15 -69.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.221 2.614 . . . . 0.0 112.309 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -51.49 -48.62 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.473 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -68.45 -19.55 64.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 3' ' ' ILE . . . -76.17 -47.95 22.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.49 -37.07 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 6.3 mmtp -68.54 -35.64 77.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.487 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -65.11 -45.54 84.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.357 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 15' ' ' VAL . 25.5 t -70.78 -37.65 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.957 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.23 -29.95 76.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.141 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 9.5 mmmt -72.3 -35.36 68.66 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CA ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.562 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 HG22 ' A' ' 22' ' ' ILE . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.439 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 24' ' ' ILE . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -51.41 -22.0 2.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -107.95 -10.12 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 17.7 t80 -72.96 -33.23 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.86 34.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.71 72.26 21.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.768 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 11.2 Cg_endo -54.14 177.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.081 2.521 . . . . 0.0 112.397 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' LYS . 3.3 mppt? -67.86 -12.3 60.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.962 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 25.2 mttt -35.19 -74.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER 77.41 -57.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.569 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' N ' ' CG ' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -73.26 116.22 13.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.239 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -157.52 57.43 0.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.952 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 12.6 mm -136.84 -51.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.573 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 60.3 Cg_endo -97.54 -76.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 112.71 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -39.32 -63.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.0 110.407 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -22.83 25.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.637 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -73.02 -42.49 63.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.529 HG22 ' N ' ' A' ' 9' ' ' LYS . 1.7 tt -68.23 -33.39 60.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.276 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -77.61 -42.38 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 109.869 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 m -64.52 -32.68 74.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.684 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 7' ' ' ALA . 13.1 t -68.38 -44.29 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.495 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.6 -31.97 72.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.172 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -80.04 -29.27 39.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' CD1' ' C ' ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.553 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.553 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 35' ' ' LEU . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -39.49 -38.93 0.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -74.96 -45.07 44.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.595 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.43 ' HB3' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -63.6 -37.75 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 ' CD1' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -125.04 55.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HG2' ' N ' ' A' ' 37' ' ' PRO . 4.6 tttt -78.72 -63.9 0.39 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.531 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 77.9 Cg_endo -82.98 53.43 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.722 2.281 . . . . 0.0 112.398 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -22.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -35.03 62.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER 57.73 178.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.575 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -149.37 -57.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.005 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.041 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -107.25 -98.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.57 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -144.86 41.36 0.31 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.569 0.224 . . . . 0.0 111.378 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 97.8 Cg_endo -82.03 -15.05 9.45 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.619 2.213 . . . . 0.0 112.72 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 3.4 mt -35.55 -77.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.763 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.71 -29.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.543 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.96 -44.55 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 9.7 pt -66.99 -23.61 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.999 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -74.24 -44.29 53.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.662 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -67.94 -31.62 71.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.452 ' O ' HG21 ' A' ' 15' ' ' VAL . 60.5 t -68.18 -46.6 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.85 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.826 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 17.1 mmtt -81.81 -23.96 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' C ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.523 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 34' ' ' PHE . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -46.16 -34.19 4.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -79.74 -25.33 41.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.694 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.14 -31.62 72.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.816 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.15 12.7 13.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.206 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.538 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 mptp? -88.95 -59.01 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 54.3 Cg_endo -89.96 30.69 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 -73.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 3.7 mmmt -97.54 -74.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER 179.07 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.862 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD3' ' HB3' ' A' ' 37' ' ' PRO . 21.6 mmmt 76.6 40.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.943 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.049 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.831 0.348 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -112.59 -24.37 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.81 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.2 mp -86.64 -44.32 0.56 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.417 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 86.6 Cg_exo -47.93 -33.12 19.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.75 2.3 . . . . 0.0 112.646 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.483 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.51 -48.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.95 0.405 . . . . 0.0 110.798 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' N ' HG21 ' A' ' 5' ' ' ILE . 4.3 tptm -71.62 -18.41 62.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.153 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.9 36.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -67.52 -36.76 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.357 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -63.86 -45.24 90.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.433 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 m -55.91 -39.41 71.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.7 t -60.8 -49.51 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.64 -34.34 20.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.569 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -39.71 76.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -46.24 -42.07 13.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -33.0 25.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.154 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -16.56 20.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -162.51 91.46 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.537 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -123.62 -66.23 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HD3' ' CG ' ' A' ' 36' ' ' LYS . 61.7 Cg_endo -85.63 -172.28 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.392 2.061 . . . . 0.0 112.54 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.69 6.0 9.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 40' ' ' ARG . 24.7 mtmt -63.38 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.85 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 7.0 ttm180 73.18 135.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -18.42 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.129 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' O ' ' CD1' ' A' ' 5' ' ' ILE . 2.0 mptp? -160.38 -57.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.501 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 7.0 mt -87.67 -58.62 0.28 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.7 Cg_endo -65.7 -18.43 58.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.492 2.128 . . . . 0.0 113.411 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -47.11 -73.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.131 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -50.25 -23.41 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.05 -43.78 56.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 20.5 tt -65.86 -23.56 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 17.7 mmtp -74.6 -46.92 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.492 HG12 ' CG2' ' A' ' 15' ' ' VAL . 27.1 t -75.91 -24.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 110.367 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.23 -27.37 70.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.67 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 20.3 mmtt -85.29 -36.09 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' CG2' HG12 ' A' ' 11' ' ' VAL . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' N ' ' CG ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.27 -18.99 65.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 24.4 t-20 -89.54 -32.22 17.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -26.0 62.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.681 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' C ' ' A' ' 36' ' ' LYS . 2.5 mm? -78.49 -84.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.848 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER 17.83 65.32 0.22 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.744 0.653 . . . . 0.0 112.041 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 19.0 Cg_endo -59.94 111.99 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.729 2.286 . . . . 0.0 111.955 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.82 41.09 5.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 46.0 mmtm 40.81 32.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 71.57 -59.56 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 7.82 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.811 0.339 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -100.24 145.45 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.873 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mt -88.84 -41.85 0.45 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.674 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.5 Cg_endo -82.39 -3.29 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.706 2.271 . . . . 0.0 112.828 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -53.56 -37.76 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.068 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' N ' HG22 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -73.8 -32.4 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.63 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.453 HD12 HG21 ' A' ' 8' ' ' ILE . 3.2 tt -71.27 -34.75 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -73.87 -28.75 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 3.1 m -73.4 -34.22 65.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.94 -34.53 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.722 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.86 -34.12 62.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.754 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER -78.69 -30.35 46.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.489 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 -51.62 -30.78 22.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 1.4 t-20 -77.89 -41.49 36.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -80.86 4.41 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.784 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' C ' ' HD3' ' A' ' 37' ' ' PRO . 20.3 tp -144.34 65.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 33' ' ' ASN . 5.0 pttm -117.28 60.88 2.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.0 Cg_exo -40.76 -45.9 4.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.767 2.311 . . . . 0.0 112.531 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -41.88 -42.08 2.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.272 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 -18.38 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.35 107.05 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -80.0 102.4 9.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.998 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.55 75.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 35.0 mt 60.09 52.28 3.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 57.8 Cg_endo -70.97 -13.49 31.67 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.128 2.552 . . . . 0.0 112.72 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.9 mt -46.37 -48.33 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.702 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 6.4 mttt -58.21 -20.72 43.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.555 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -73.03 -50.49 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 9' ' ' LYS . 19.6 tt -61.02 -29.56 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.897 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.531 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -59.45 -40.05 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.418 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.27 -54.42 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.92 60.06 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.559 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -84.07 -27.21 28.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.577 ' NE ' ' N ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.577 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.453 ' O ' HD21 ' A' ' 35' ' ' LEU . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.83 -8.27 56.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.995 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -34.37 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.205 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -130.02 77.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -124.66 48.75 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 58.6 Cg_endo -73.57 -35.74 4.45 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.798 2.332 . . . . 0.0 112.496 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER 84.53 -42.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.324 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -29.94 -56.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 136.84 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -78.84 78.6 5.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.456 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.326 -179.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.761 0.315 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -148.77 -80.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.186 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.53 HG13 ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -153.96 -67.18 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.53 ' CD ' HG13 ' A' ' 3' ' ' ILE . 36.8 Cg_endo -66.26 -17.03 53.7 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.806 2.337 . . . . 0.0 113.255 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 6' ' ' LYS . 2.5 pp -54.51 -43.81 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' N ' HD12 ' A' ' 5' ' ' ILE . 13.0 pttm -67.08 -16.59 64.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.583 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.51 -47.03 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.922 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 9' ' ' LYS . 10.8 tt -66.21 -33.06 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.628 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -69.42 -39.35 77.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.567 179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 m -61.36 -38.59 87.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.425 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.52 -39.91 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.25 72.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.499 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -83.43 -27.8 29.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' N ' ' CG ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -61.07 -24.74 66.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.485 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -79.69 -45.28 19.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.625 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.3 -28.87 45.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.49 -7.77 27.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.255 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.01 -49.76 91.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 91.2 Cg_endo -79.23 91.36 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.606 2.204 . . . . 0.0 112.532 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -71.36 -14.61 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -9.53 21.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER 72.83 -67.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -37.63 136.42 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.821 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.092 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -171.01 44.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.62 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.8 tt -94.67 -30.28 0.28 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 67.8 Cg_endo -76.38 -25.01 10.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.846 1.698 . . . . 0.0 113.068 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 2' ' ' LYS . 4.5 mt -60.57 -66.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.061 0.457 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -58.65 -21.65 54.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.327 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -76.71 -44.03 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.516 ' HA ' ' CG2' ' A' ' 11' ' ' VAL . 5.1 tt -68.7 -26.63 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' N ' HG21 ' A' ' 8' ' ' ILE . 6.6 mttm -75.13 -39.23 60.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -41.76 83.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 14.3 m -67.09 -44.6 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.453 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 11' ' ' VAL . . . -61.64 -37.84 94.89 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.414 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -73.71 -24.0 59.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HB1' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.579 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 19' ' ' LEU . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.579 ' ND2' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.554 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 1.5 t80 -53.52 -32.58 51.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -77.54 -39.82 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.628 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.16 -12.53 61.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 35' ' ' LEU . 46.1 tp -92.72 5.07 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.836 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.62 72.13 20.45 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 165.72 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.831 2.354 . . . . 0.0 112.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -47.99 -28.42 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 45.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -65.29 114.47 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -82.33 177.84 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.834 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -100.39 23.41 10.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' CG2' ' A' ' 3' ' ' ILE . 6.9 mm 62.04 52.68 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 33.7 Cg_endo -65.07 -24.14 60.01 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.762 2.308 . . . . 0.0 112.367 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.3 OUTLIER -37.28 -69.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HG2' HG21 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -38.4 -35.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.74 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -62.48 -54.28 42.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 12.5 tt -60.7 -16.23 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.688 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mmmt -82.47 -32.2 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.767 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.509 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 58.9 m -71.1 -35.54 71.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 12' ' ' GLY . 2.4 p -75.24 -45.17 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 110.082 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -68.14 -29.59 73.43 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.528 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -78.66 -28.63 45.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.547 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.3 t80 -47.78 -25.38 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.511 ' HA ' ' CD ' ' A' ' 36' ' ' LYS . 3.3 t30 -90.14 -30.64 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.47 -40.42 95.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.186 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.32 45.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -48.07 -47.33 65.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.489 . . . . 0.0 110.746 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 90.5 Cg_endo -83.11 -94.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.854 2.37 . . . . 0.0 112.209 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER -175.16 44.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.87 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 59.48 22.27 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 65.18 10.12 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -60.42 176.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.111 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.782 0.325 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' CB ' ' HD2' ' A' ' 4' ' ' PRO . 5.3 mttp -61.6 -172.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.576 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.4 mm -84.12 -40.58 0.73 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.699 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 72.5 Cg_exo -41.44 -64.68 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.655 2.236 . . . . 0.0 112.871 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -32.54 -67.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.611 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 13.0 ptpt -57.42 -29.23 63.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -71.78 -34.73 69.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 HG21 ' N ' ' A' ' 9' ' ' LYS . 17.7 tt -77.54 -27.7 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' N ' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.95 -29.0 60.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.7 m -74.06 -43.18 58.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.238 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 15' ' ' VAL . 93.7 t -70.86 -42.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.51 78.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.28 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -81.43 -24.43 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.49 ' CD ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 21' ' ' ALA . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' CB ' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 3.5 t80 -65.84 -22.2 66.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -91.02 -22.64 20.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -77.01 -28.59 55.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -89.08 -3.78 58.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.556 ' CG ' ' O ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.26 60.71 38.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 121.298 0.571 . . . . 0.0 111.056 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.1 Cg_endo -87.0 40.57 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.099 2.533 . . . . 0.0 112.262 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.5 mmtt -52.33 -20.43 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' N ' ' HD3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.87 5.32 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.623 0.249 . . . . 0.0 111.563 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 48.58 -172.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.761 0.315 . . . . 0.0 110.691 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -42.68 -52.68 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.059 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -41.87 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.066 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.49 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -157.96 51.01 0.44 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 98.1 Cg_endo -80.32 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.801 2.334 . . . . 0.0 112.406 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 3.3 mt -51.45 -66.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.93 0.395 . . . . 0.0 110.92 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HE3' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -41.12 -30.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -66.24 -43.23 87.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.719 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -67.9 -21.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.519 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -72.35 -45.34 60.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.3 m -66.53 -45.03 80.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 8' ' ' ILE . 1.4 p -66.27 -41.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.875 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -59.26 -41.07 96.62 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.863 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.29 -41.86 89.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 11' ' ' VAL . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.582 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 28' ' ' ALA . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -38.74 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 5.6 m-80 -71.34 -18.04 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -83.71 -24.87 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.609 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.453 ' C ' ' HG2' ' A' ' 36' ' ' LYS . 56.7 tp -104.33 -51.92 3.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.673 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HG2' ' C ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 30.54 92.67 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.354 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.67 -160.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.572 2.181 . . . . 0.0 112.064 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.49 41.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.232 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp 42.23 56.14 3.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.483 ' HD3' ' HB2' ' A' ' 38' ' ' LYS . 3.0 ptm180 -156.56 21.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -126.11 59.84 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.164 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.763 0.316 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' O ' HG12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -103.0 -6.93 21.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.026 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 mp -84.45 -44.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.3 Cg_endo -84.09 20.05 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.89 2.394 . . . . 0.0 112.539 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -43.46 -84.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.21 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.39 -31.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 5' ' ' ILE . . . -63.69 -52.27 61.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -59.85 -22.54 24.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.49 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.474 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 3.9 m -65.88 -23.94 66.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.3 -47.1 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.553 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -59.83 -35.39 86.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.617 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' CG ' ' HA ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -78.92 -26.79 43.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' GLY . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.576 ' ND2' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 4.6 t80 -59.64 -34.26 72.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -72.57 -26.81 61.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.487 ' CB ' HD21 ' A' ' 35' ' ' LEU . 10.6 m-85 -74.31 -30.2 61.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -137.6 82.3 1.92 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 111.018 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 57.73 5.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.841 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 72.5 Cg_endo -77.05 168.37 23.45 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.755 2.303 . . . . 0.0 112.529 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.1 -10.82 59.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -97.8 0.23 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.041 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 67.94 162.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.666 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt 67.29 -176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.128 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.865 0.364 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 3.33 9.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.865 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.56 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -87.82 -44.95 0.49 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.129 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 78.4 Cg_exo -50.32 -25.59 14.01 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.804 2.336 . . . . 0.0 112.604 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.516 ' CG2' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -57.93 -49.63 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.084 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -60.07 -30.32 69.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.69 91.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.277 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.3 tt -61.4 -39.15 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -64.84 -39.2 93.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -61.77 -41.27 97.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.9 t -57.97 -48.49 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.2 -37.51 64.64 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.245 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 3.9 mmmp? -71.57 -33.62 69.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 16' ' ' GLY . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' NE ' ' N ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.582 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 21' ' ' ALA . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -63.35 -42.35 98.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -53.06 -31.7 42.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 109.869 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.459 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 80.5 t80 -73.68 -33.89 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.212 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.494 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -89.57 -23.08 22.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER 39.58 101.23 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.365 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HG3' ' CE2' ' A' ' 32' ' ' PHE . 12.4 Cg_endo -55.47 -70.49 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.802 2.334 . . . . 0.0 111.828 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -170.57 2.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -83.21 46.66 1.15 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.39 121.03 16.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -89.79 107.47 19.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.582 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -138.04 39.87 0.42 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.752 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 66.1 Cg_endo -85.52 24.21 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.613 2.209 . . . . 0.0 112.353 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 HD13 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -41.07 -44.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.541 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 36.5 mmtt -66.86 -28.59 68.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.935 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -74.83 -44.68 47.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.912 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 5' ' ' ILE . 16.4 pt -67.09 -20.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -77.82 -47.91 17.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.581 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.509 ' N ' ' HD2' ' A' ' 9' ' ' LYS . 32.5 m -66.74 -34.31 77.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.186 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.6 t -71.56 -45.87 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.551 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.53 -23.58 66.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.184 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -80.82 -32.17 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' N ' HD13 ' A' ' 19' ' ' LEU . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.556 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.556 ' CD1' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.496 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' HD12 ' A' ' 35' ' ' LEU . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -24.43 0.48 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 12.9 t-20 -91.82 -33.08 15.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 1.7 t80 -61.58 -35.38 77.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.016 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -120.12 67.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.008 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 10.5 mttt -90.01 -48.69 0.38 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 64.5 Cg_endo -87.34 -175.97 1.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.742 2.294 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -133.7 -37.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.35 1.58 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 14.7 ttm-85 -160.49 95.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.969 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -71.11 102.14 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.755 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.08 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -138.67 -60.76 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.505 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tt -154.43 53.36 0.89 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.919 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 97.0 Cg_endo -85.69 7.36 5.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.875 2.383 . . . . 0.0 112.814 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -61.55 -73.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.343 . . . . 0.0 111.086 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -25.49 12.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.52 -44.12 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 9' ' ' LYS . 3.4 tt -69.13 -28.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.7 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.535 ' N ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.6 -35.69 57.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.522 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.4 m -69.45 -38.33 77.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.446 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -70.69 -42.11 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.558 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.75 75.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.599 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 13.7 mttt -81.69 -28.79 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD13 ' HD3' ' A' ' 20' ' ' ARG . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HD3' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.568 ' N ' ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -64.91 -15.74 62.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.44 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 6.8 t30 -89.62 -32.57 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.55 -42.72 86.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 111.045 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.459 ' HG ' ' N ' ' A' ' 36' ' ' LYS . 4.3 tp -67.29 -80.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.622 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 39.11 94.95 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.77 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.37 142.75 41.71 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.697 2.265 . . . . 0.0 111.788 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -90.73 -49.02 6.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.376 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' ARG . 3.0 mttm -96.58 6.21 49.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.328 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 35.44 66.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.921 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 40' ' ' ARG . 10.1 mmtt -36.99 141.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.06 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.921 0.391 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -97.14 -166.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.854 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.543 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 40.9 mt 71.52 44.85 0.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.622 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 83.5 Cg_endo -83.74 -4.08 10.64 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.742 2.295 . . . . 0.0 112.51 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -43.93 -37.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' N ' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -68.0 -24.41 65.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -76.5 -40.15 51.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -66.32 -36.91 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.838 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -65.87 -42.44 90.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -60.05 -40.75 90.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 7' ' ' ALA . 98.7 t -66.45 -37.18 79.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.699 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.85 -28.78 70.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.519 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -80.82 -36.97 30.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' O ' HG22 ' A' ' 24' ' ' ILE . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.475 ' O ' HD12 ' A' ' 24' ' ' ILE . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.521 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.521 HG23 ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' N ' ' CD1' ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.417 ' O ' HG21 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 28' ' ' ALA . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -61.38 -43.96 97.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 18.3 t-20 -67.07 -21.56 65.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.82 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -40.58 66.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 36' ' ' LYS . 7.1 mt -100.99 -29.1 12.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER 35.56 58.99 2.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 25.0 Cg_exo -63.07 102.12 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -56.42 -36.66 69.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.585 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.58 28.69 1.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 57.66 174.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.25 148.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.654 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.988 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.4 mttm -72.91 -146.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.591 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.549 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 mm -129.36 48.01 3.32 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.563 0.221 . . . . 0.0 111.539 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 76.4 Cg_exo -49.01 -27.02 11.13 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.235 1.956 . . . . 0.0 112.115 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' HG23 ' A' ' 8' ' ' ILE . 1.1 pp -61.81 -35.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -72.83 -25.47 61.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -70.86 -39.43 72.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -73.21 -34.72 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.726 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -70.37 -35.54 73.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.59 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -67.32 -45.4 76.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 12' ' ' GLY . 17.0 m -70.34 -44.7 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.317 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 11' ' ' VAL . . . -66.41 -26.41 72.72 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.399 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt -84.25 -19.93 33.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.55 HD13 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.55 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 31' ' ' VAL . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' CG ' ' A' ' 34' ' ' PHE . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 27' ' ' THR . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -51.67 -31.74 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.39 -28.16 41.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.59 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m-30 -76.1 -28.67 57.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.463 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.21 -66.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 92.61 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.143 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . 25.9 Cg_exo -62.14 163.68 19.21 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.698 2.265 . . . . 0.0 112.007 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LYS . 1.3 pttm -63.85 72.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 34.8 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -112.49 88.67 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -133.21 -70.56 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.22 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HG2' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -118.89 -20.84 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.495 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.5 mt -95.86 -47.63 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.244 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 96.5 Cg_endo -89.49 24.37 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 112.502 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 6' ' ' LYS . 11.6 pt -49.78 -48.62 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.44 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' N ' HG13 ' A' ' 5' ' ' ILE . 1.6 mmtt -60.12 -23.72 64.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.709 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.02 -40.66 62.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.795 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -64.13 -38.63 82.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.06 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 2.0 mmtt -67.38 -38.31 84.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.25 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 m -57.68 -40.97 80.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.6 -48.39 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.789 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.1 -25.47 56.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.959 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 2.5 mttp -82.63 -35.17 27.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.532 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 HG12 HD23 ' A' ' 35' ' ' LEU . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 21.0 t80 -59.93 -13.64 12.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.435 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 66.8 t30 -115.63 -2.77 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.355 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 5.3 t80 -98.2 -52.65 3.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -106.62 -34.41 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 31.37 76.34 0.38 Allowed Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' LYS . 88.6 Cg_endo -85.02 -97.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.974 2.449 . . . . 0.0 112.311 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.8 -69.77 0.05 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.986 0.422 . . . . 0.0 110.502 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -103.48 -9.96 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.7 ttm180 83.01 78.58 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 39.67 51.17 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.144 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 8.6 mmtt 81.14 21.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.987 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -153.45 66.79 5.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.294 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.92 -22.49 73.86 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.68 2.253 . . . . 0.0 111.882 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' O ' HG23 ' A' ' 8' ' ' ILE . 2.2 mp -43.16 -73.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.196 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -42.79 -27.17 0.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HA ' HG23 ' A' ' 10' ' ' THR . . . -77.76 -43.47 30.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 9' ' ' LYS . 18.3 tt -74.02 -28.97 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.643 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 8' ' ' ILE . 2.9 mtpt -77.17 -34.84 56.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.479 HG22 ' N ' ' A' ' 11' ' ' VAL . 6.0 t -71.57 -30.59 66.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.53 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.479 ' N ' HG22 ' A' ' 10' ' ' THR . 24.6 t -78.52 -32.37 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.073 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.4 -31.17 76.25 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.739 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -85.49 -24.28 27.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -54.24 -24.42 18.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -109.94 7.13 23.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 2.0 m-30 -101.85 -24.31 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -98.09 48.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.057 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -136.41 44.18 0.97 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 72.9 Cg_endo -76.86 118.19 4.72 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.742 2.295 . . . . 0.0 112.145 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -77.09 -45.97 25.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.18 27.04 9.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 44.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -50.08 150.0 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.126 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.735 HD13 ' C ' ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.871 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 27' ' ' THR . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' C ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.952 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.952 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' THR . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.827 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 18' ' ' GLY . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' VAL . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 27' ' ' THR . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.687 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 27' ' ' THR . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' THR . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 17.4 mmtm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.624 ' N ' HD23 ' A' ' 19' ' ' LEU . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.832 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 27' ' ' THR . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.3 t80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 18' ' ' GLY . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.712 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' THR . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.606 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.497 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 4.6 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mmmp? . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 20' ' ' ARG . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.059 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.059 HG23 ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.787 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 27' ' ' THR . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 13.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 19' ' ' LEU . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.689 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' OD1' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.988 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' THR . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 19' ' ' LEU . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.769 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.769 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' CD ' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.638 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.902 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 3' ' ' ILE . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -56.27 82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.95 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 1.8 tt -173.64 58.77 0.22 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.367 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 64.3 Cg_endo -93.15 -69.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.221 2.614 . . . . 0.0 112.309 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -51.49 -48.62 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.473 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -68.45 -19.55 64.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 3' ' ' ILE . . . -76.17 -47.95 22.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -37.07 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 6.3 mmtp -68.54 -35.64 77.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.487 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -65.11 -45.54 84.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.357 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' O ' HG22 ' A' ' 15' ' ' VAL . 25.5 t -70.78 -37.65 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.957 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.23 -29.95 76.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.141 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.5 mmmt -72.3 -35.36 68.66 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -51.41 -22.0 2.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -107.95 -10.12 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 17.7 t80 -72.96 -33.23 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.86 34.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.71 72.26 21.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.768 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 11.2 Cg_endo -54.14 177.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.081 2.521 . . . . 0.0 112.397 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' LYS . 3.3 mppt? -67.86 -12.3 60.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.962 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 25.2 mttt -35.19 -74.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 77.41 -57.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.569 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' N ' ' CG ' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -73.26 116.22 13.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.239 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -157.52 57.43 0.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.952 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.6 mm -136.84 -51.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.633 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 60.3 Cg_endo -97.54 -76.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 112.71 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.879 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -39.32 -63.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.0 110.407 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -22.83 25.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.637 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 3' ' ' ILE . . . -73.02 -42.49 63.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.879 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.7 tt -68.23 -33.39 60.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.276 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -77.61 -42.38 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 109.869 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 m -64.52 -32.68 74.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.684 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 7' ' ' ALA . 13.1 t -68.38 -44.29 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.495 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.6 -31.97 72.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.172 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -80.04 -29.27 39.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.735 ' C ' HD13 ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.871 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.793 HG13 HD11 ' A' ' 35' ' ' LEU . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -39.49 -38.93 0.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -74.96 -45.07 44.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.595 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.717 ' HB3' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -63.6 -37.75 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.793 HD11 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -125.04 55.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 37' ' ' PRO . 4.6 tttt -78.72 -63.9 0.39 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.533 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 77.9 Cg_endo -82.98 53.43 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.722 2.281 . . . . 0.0 112.398 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -22.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -35.03 62.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER 57.73 178.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.575 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -149.37 -57.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.005 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.041 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' C ' HD13 ' A' ' 3' ' ' ILE . 15.0 mttp -107.25 -98.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.588 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -144.86 41.36 0.31 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.569 0.224 . . . . 0.0 111.378 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 97.8 Cg_endo -82.03 -15.05 9.45 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.619 2.213 . . . . 0.0 112.72 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 3.4 mt -35.55 -77.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.763 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -40.71 -29.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.543 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -72.96 -44.55 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 9.7 pt -66.99 -23.61 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.999 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 6' ' ' LYS . 3.2 mtmt -74.24 -44.29 53.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.662 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -67.94 -31.62 71.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 7' ' ' ALA . 60.5 t -68.18 -46.6 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.85 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.826 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -81.81 -23.96 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' C ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.952 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.952 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' THR . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -46.16 -34.19 4.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 15.9 t-20 -79.74 -25.33 41.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.694 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.14 -31.62 72.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.816 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.15 12.7 13.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.206 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 mptp? -88.95 -59.01 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 54.3 Cg_endo -89.96 30.69 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 -73.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' LYS . 3.7 mmmt -97.54 -74.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER 179.07 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.862 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 37' ' ' PRO . 21.6 mmmt 76.6 40.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.943 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.049 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.831 0.348 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -112.59 -24.37 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.81 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.2 mp -86.64 -44.32 0.56 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.417 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 86.6 Cg_exo -47.93 -33.12 19.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.75 2.3 . . . . 0.0 112.646 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -72.51 -48.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.95 0.405 . . . . 0.0 110.798 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.591 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.3 tptm -71.62 -18.41 62.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.153 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.9 36.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.701 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.52 -36.76 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.357 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -63.86 -45.24 90.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.433 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 m -55.91 -39.41 71.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' VAL . 39.7 t -60.8 -49.51 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.64 -34.34 20.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.569 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -39.71 76.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 11' ' ' VAL . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.827 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -46.24 -42.07 13.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -33.0 25.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.154 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -16.56 20.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -162.51 91.46 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -123.62 -66.23 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' CG ' ' A' ' 36' ' ' LYS . 61.7 Cg_endo -85.63 -172.28 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.392 2.061 . . . . 0.0 112.54 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.69 6.0 9.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ARG . 24.7 mtmt -63.38 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.85 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 7.0 ttm180 73.18 135.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -18.42 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.129 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.771 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.0 mptp? -160.38 -57.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 7.0 mt -87.67 -58.62 0.28 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.7 Cg_endo -65.7 -18.43 58.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.492 2.128 . . . . 0.0 113.411 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -47.11 -73.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.131 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -50.25 -23.41 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -74.05 -43.78 56.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 5' ' ' ILE . 20.5 tt -65.86 -23.56 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 17.7 mmtp -74.6 -46.92 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 15' ' ' VAL . 27.1 t -75.91 -24.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 110.367 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.23 -27.37 70.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.67 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 20.3 mmtt -85.29 -36.09 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.534 ' CG2' HG13 ' A' ' 11' ' ' VAL . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 18' ' ' GLY . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' HA ' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' VAL . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 27' ' ' THR . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.27 -18.99 65.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 24.4 t-20 -89.54 -32.22 17.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -26.0 62.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.681 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' C ' ' A' ' 36' ' ' LYS . 2.5 mm? -78.49 -84.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.848 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER 17.83 65.32 0.22 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.744 0.653 . . . . 0.0 112.041 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 19.0 Cg_endo -59.94 111.99 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.729 2.286 . . . . 0.0 111.955 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.82 41.09 5.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 46.0 mmtm 40.81 32.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 71.57 -59.56 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 7.82 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.811 0.339 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -100.24 145.45 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.873 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mt -88.84 -41.85 0.45 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.674 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.5 Cg_endo -82.39 -3.29 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.706 2.271 . . . . 0.0 112.828 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -53.56 -37.76 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.068 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.8 -32.4 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.63 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.2 tt -71.27 -34.75 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -73.87 -28.75 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 3.1 m -73.4 -34.22 65.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.94 -34.53 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.722 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.86 -34.12 62.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.754 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER -78.69 -30.35 46.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 -51.62 -30.78 22.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 1.4 t-20 -77.89 -41.49 36.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -80.86 4.41 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.784 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' A' ' 37' ' ' PRO . 20.3 tp -144.34 65.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ASN . 5.0 pttm -117.28 60.88 2.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.0 Cg_exo -40.76 -45.9 4.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.767 2.311 . . . . 0.0 112.531 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -41.88 -42.08 2.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.272 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 -18.38 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -72.35 107.05 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -80.0 102.4 9.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.998 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.55 75.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 3' ' ' ILE . 35.0 mt 60.09 52.28 3.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 57.8 Cg_endo -70.97 -13.49 31.67 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.128 2.552 . . . . 0.0 112.72 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.791 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.9 mt -46.37 -48.33 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.702 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG3' HG22 ' A' ' 3' ' ' ILE . 6.4 mttt -58.21 -20.72 43.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.555 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -73.03 -50.49 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 5' ' ' ILE . 19.6 tt -61.02 -29.56 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.897 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.531 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -59.45 -40.05 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.418 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.27 -54.42 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.92 60.06 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.559 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -84.07 -27.21 28.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.687 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 27' ' ' THR . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.83 -8.27 56.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.995 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -34.37 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.205 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.02 77.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -124.66 48.75 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 58.6 Cg_endo -73.57 -35.74 4.45 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.798 2.332 . . . . 0.0 112.496 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER 84.53 -42.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.324 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -29.94 -56.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 136.84 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -78.84 78.6 5.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.456 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.326 -179.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.761 0.315 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' C ' HG12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -148.77 -80.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.186 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.534 HG13 ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -153.96 -67.18 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' CD ' HG13 ' A' ' 3' ' ' ILE . 36.8 Cg_endo -66.26 -17.03 53.7 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.806 2.337 . . . . 0.0 113.255 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 6' ' ' LYS . 2.5 pp -54.51 -43.81 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 5' ' ' ILE . 13.0 pttm -67.08 -16.59 64.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.583 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -77.51 -47.03 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.8 tt -66.21 -33.06 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.628 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -39.35 77.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.567 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 m -61.36 -38.59 87.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.425 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.52 -39.91 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.25 72.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.499 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -83.43 -27.8 29.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' THR . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -61.07 -24.74 66.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -79.69 -45.28 19.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.625 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.3 -28.87 45.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.49 -7.77 27.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.255 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.01 -49.76 91.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 91.2 Cg_endo -79.23 91.36 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.606 2.204 . . . . 0.0 112.532 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -71.36 -14.61 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -9.53 21.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER 72.83 -67.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.675 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -37.63 136.42 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.821 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.092 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -171.01 44.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.701 HG22 ' HD3' ' A' ' 4' ' ' PRO . 4.8 tt -94.67 -30.28 0.28 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.701 ' HD3' HG22 ' A' ' 3' ' ' ILE . 67.8 Cg_endo -76.38 -25.01 10.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.846 1.698 . . . . 0.0 113.068 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 mt -60.57 -66.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.061 0.457 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -58.65 -21.65 54.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.327 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 11' ' ' VAL . . . -76.71 -44.03 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.1 tt -68.7 -26.63 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 6' ' ' LYS . 6.6 mttm -75.13 -39.23 60.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -41.76 83.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 14.3 m -67.09 -44.6 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.453 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 11' ' ' VAL . . . -61.64 -37.84 94.89 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.414 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 17.4 mmtm -73.71 -24.0 59.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.624 ' N ' HD23 ' A' ' 19' ' ' LEU . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.832 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 27' ' ' THR . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 1.5 t80 -53.52 -32.58 51.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -77.54 -39.82 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.628 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.16 -12.53 61.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 46.1 tp -92.72 5.07 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.836 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.62 72.13 20.45 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 165.72 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.831 2.354 . . . . 0.0 112.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -47.99 -28.42 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 45.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -65.29 114.47 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -82.33 177.84 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.834 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -100.39 23.41 10.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 3' ' ' ILE . 6.9 mm 62.04 52.68 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 33.7 Cg_endo -65.07 -24.14 60.01 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.762 2.308 . . . . 0.0 112.367 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -37.28 -69.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -38.4 -35.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.74 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -62.48 -54.28 42.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 5' ' ' ILE . 12.5 tt -60.7 -16.23 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.688 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mmmt -82.47 -32.2 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.767 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 58.9 m -71.1 -35.54 71.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 12' ' ' GLY . 2.4 p -75.24 -45.17 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 110.082 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -68.14 -29.59 73.43 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.528 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -78.66 -28.63 45.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.3 t80 -47.78 -25.38 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 36' ' ' LYS . 3.3 t30 -90.14 -30.64 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.47 -40.42 95.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.186 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -110.32 45.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -48.07 -47.33 65.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.489 . . . . 0.0 110.746 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 90.5 Cg_endo -83.11 -94.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.854 2.37 . . . . 0.0 112.209 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER -175.16 44.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.87 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 59.48 22.27 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 65.18 10.12 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -60.42 176.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.111 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' C ' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.782 0.325 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' HD2' ' A' ' 4' ' ' PRO . 5.3 mttp -61.6 -172.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.74 ' N ' HD13 ' A' ' 3' ' ' ILE . 1.4 mm -84.12 -40.58 0.73 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.699 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 72.5 Cg_exo -41.44 -64.68 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.655 2.236 . . . . 0.0 112.871 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -32.54 -67.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.611 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 13.0 ptpt -57.42 -29.23 63.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -71.78 -34.73 69.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.918 HG22 ' O ' ' A' ' 5' ' ' ILE . 17.7 tt -77.54 -27.7 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.557 ' HE3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.95 -29.0 60.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.7 m -74.06 -43.18 58.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.238 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 15' ' ' VAL . 93.7 t -70.86 -42.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.51 78.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.28 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -81.43 -24.43 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 18' ' ' GLY . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.712 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 35' ' ' LEU . 3.5 t80 -65.84 -22.2 66.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -91.02 -22.64 20.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -77.01 -28.59 55.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -89.08 -3.78 58.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.26 60.71 38.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 121.298 0.571 . . . . 0.0 111.056 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.1 Cg_endo -87.0 40.57 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.099 2.533 . . . . 0.0 112.262 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.5 mmtt -52.33 -20.43 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.87 5.32 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.623 0.249 . . . . 0.0 111.563 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 48.58 -172.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.761 0.315 . . . . 0.0 110.691 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -42.68 -52.68 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.059 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -41.87 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.066 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -157.96 51.01 0.44 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 98.1 Cg_endo -80.32 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.801 2.334 . . . . 0.0 112.406 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.001 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 mt -51.45 -66.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.93 0.395 . . . . 0.0 110.92 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -30.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -66.24 -43.23 87.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.719 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.001 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -67.9 -21.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.519 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -45.34 60.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.3 m -66.53 -45.03 80.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.4 p -66.27 -41.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.875 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -59.26 -41.07 96.62 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.863 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.29 -41.86 89.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 11' ' ' VAL . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' THR . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -38.74 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 5.6 m-80 -71.34 -18.04 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -83.71 -24.87 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.609 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' C ' ' HG2' ' A' ' 36' ' ' LYS . 56.7 tp -104.33 -51.92 3.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.673 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER 30.54 92.67 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.354 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.67 -160.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.572 2.181 . . . . 0.0 112.064 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.49 41.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.232 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp 42.23 56.14 3.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' HD3' ' HB2' ' A' ' 38' ' ' LYS . 3.0 ptm180 -156.56 21.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -126.11 59.84 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.164 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.763 0.316 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -103.0 -6.93 21.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.026 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 mp -84.45 -44.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 91.3 Cg_endo -84.09 20.05 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.89 2.394 . . . . 0.0 112.539 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.46 -84.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.21 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.39 -31.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -63.69 -52.27 61.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -59.85 -22.54 24.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.49 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 3.9 m -65.88 -23.94 66.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 7' ' ' ALA . 61.4 t -75.3 -47.1 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.553 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.83 -35.39 86.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.617 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' CG ' ' HA ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -78.92 -26.79 43.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.606 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.497 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.606 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 4.6 t80 -59.64 -34.26 72.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -72.57 -26.81 61.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.6 m-85 -74.31 -30.2 61.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -137.6 82.3 1.92 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 111.018 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 57.73 5.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.841 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 72.5 Cg_endo -77.05 168.37 23.45 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.755 2.303 . . . . 0.0 112.529 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.1 -10.82 59.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -97.8 0.23 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.041 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 67.94 162.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.666 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt 67.29 -176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.128 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.865 0.364 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 3.33 9.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.865 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -87.82 -44.95 0.49 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.129 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 78.4 Cg_exo -50.32 -25.59 14.01 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.804 2.336 . . . . 0.0 112.604 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -57.93 -49.63 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.084 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' N ' HG23 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -60.07 -30.32 69.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -64.17 -44.69 91.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.277 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.3 tt -61.4 -39.15 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -39.2 93.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -61.77 -41.27 97.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 7' ' ' ALA . 24.9 t -57.97 -48.49 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.2 -37.51 64.64 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.245 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mmmp? -71.57 -33.62 69.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 20' ' ' ARG . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.059 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.059 HG23 ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -63.35 -42.35 98.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -53.06 -31.7 42.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 109.869 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 80.5 t80 -73.68 -33.89 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.212 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -89.57 -23.08 22.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER 39.58 101.23 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.365 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 12.4 Cg_endo -55.47 -70.49 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.802 2.334 . . . . 0.0 111.828 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -170.57 2.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -83.21 46.66 1.15 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.39 121.03 16.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -89.79 107.47 19.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' HB1' ' CG ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -138.04 39.87 0.42 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.752 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 66.1 Cg_endo -85.52 24.21 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.613 2.209 . . . . 0.0 112.353 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.681 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -41.07 -44.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.541 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' N ' HG23 ' A' ' 5' ' ' ILE . 36.5 mmtt -66.86 -28.59 68.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.935 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.83 -44.68 47.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.912 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 5' ' ' ILE . 16.4 pt -67.09 -20.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -77.82 -47.91 17.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.581 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' A' ' 9' ' ' LYS . 32.5 m -66.74 -34.31 77.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.186 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 7' ' ' ALA . 94.6 t -71.56 -45.87 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.551 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.53 -23.58 66.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.184 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -80.82 -32.17 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.787 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 27' ' ' THR . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -24.43 0.48 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 12.9 t-20 -91.82 -33.08 15.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 1.7 t80 -61.58 -35.38 77.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.016 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 67.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.008 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 10.5 mttt -90.01 -48.69 0.38 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 64.5 Cg_endo -87.34 -175.97 1.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.742 2.294 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -133.7 -37.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.35 1.58 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 14.7 ttm-85 -160.49 95.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.969 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -71.11 102.14 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.755 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.08 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -138.67 -60.76 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tt -154.43 53.36 0.89 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.919 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 97.0 Cg_endo -85.69 7.36 5.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.875 2.383 . . . . 0.0 112.814 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.71 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -61.55 -73.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.343 . . . . 0.0 111.086 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -25.49 12.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.52 -44.12 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.4 tt -69.13 -28.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.7 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD2' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.6 -35.69 57.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.522 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.4 m -69.45 -38.33 77.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.446 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -70.69 -42.11 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.558 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.75 75.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.599 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 13.7 mttt -81.69 -28.79 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.628 ' C ' HD13 ' A' ' 19' ' ' LEU . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.689 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -64.91 -15.74 62.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 6.8 t30 -89.62 -32.57 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.55 -42.72 86.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 111.045 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 36' ' ' LYS . 4.3 tp -67.29 -80.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.622 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 39.11 94.95 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.77 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.37 142.75 41.71 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.697 2.265 . . . . 0.0 111.788 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -90.73 -49.02 6.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.376 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' ARG . 3.0 mttm -96.58 6.21 49.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.328 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 35.44 66.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.921 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 40' ' ' ARG . 10.1 mmtt -36.99 141.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.06 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.921 0.391 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -97.14 -166.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.854 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.803 ' O ' HG22 ' A' ' 3' ' ' ILE . 40.9 mt 71.52 44.85 0.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.622 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 83.5 Cg_endo -83.74 -4.08 10.64 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.742 2.295 . . . . 0.0 112.51 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -43.93 -37.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -24.41 65.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -76.5 -40.15 51.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -66.32 -36.91 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.838 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -65.87 -42.44 90.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -60.05 -40.75 90.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 7' ' ' ALA . 98.7 t -66.45 -37.18 79.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.699 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.85 -28.78 70.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.519 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -80.82 -36.97 30.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ARG . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' OD1' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.988 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' THR . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -61.38 -43.96 97.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 18.3 t-20 -67.07 -21.56 65.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.82 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -40.58 66.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 36' ' ' LYS . 7.1 mt -100.99 -29.1 12.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER 35.56 58.99 2.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 25.0 Cg_exo -63.07 102.12 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -56.42 -36.66 69.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.585 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.58 28.69 1.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 57.66 174.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.25 148.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.654 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.988 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.4 mttm -72.91 -146.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.591 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 mm -129.36 48.01 3.32 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.563 0.221 . . . . 0.0 111.539 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 76.4 Cg_exo -49.01 -27.02 11.13 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.235 1.956 . . . . 0.0 112.115 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.1 pp -61.81 -35.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -72.83 -25.47 61.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 11' ' ' VAL . . . -70.86 -39.43 72.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -73.21 -34.72 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.726 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -70.37 -35.54 73.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.59 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -67.32 -45.4 76.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 12' ' ' GLY . 17.0 m -70.34 -44.7 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.317 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 11' ' ' VAL . . . -66.41 -26.41 72.72 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.399 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt -84.25 -19.93 33.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 19' ' ' LEU . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.769 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.769 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' CG ' ' A' ' 34' ' ' PHE . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -51.67 -31.74 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.39 -28.16 41.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.59 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m-30 -76.1 -28.67 57.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.463 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.21 -66.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 92.61 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.143 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . 25.9 Cg_exo -62.14 163.68 19.21 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.698 2.265 . . . . 0.0 112.007 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LYS . 1.3 pttm -63.85 72.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 34.8 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -112.49 88.67 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -133.21 -70.56 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.22 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' HG2' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -118.89 -20.84 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 mt -95.86 -47.63 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.244 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 96.5 Cg_endo -89.49 24.37 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 112.502 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 6' ' ' LYS . 11.6 pt -49.78 -48.62 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.44 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 5' ' ' ILE . 1.6 mmtt -60.12 -23.72 64.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.709 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -74.02 -40.66 62.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -64.13 -38.63 82.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.06 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 2.0 mmtt -67.38 -38.31 84.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.25 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 m -57.68 -40.97 80.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.5 t -63.6 -48.39 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.789 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.1 -25.47 56.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.959 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 2.5 mttp -82.63 -35.17 27.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 11' ' ' VAL . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.638 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 35' ' ' LEU . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 21.0 t80 -59.93 -13.64 12.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.439 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 66.8 t30 -115.63 -2.77 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.355 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 5.3 t80 -98.2 -52.65 3.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.62 -34.41 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 31.37 76.34 0.38 Allowed Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' LYS . 88.6 Cg_endo -85.02 -97.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.974 2.449 . . . . 0.0 112.311 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.8 -69.77 0.05 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.986 0.422 . . . . 0.0 110.502 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -103.48 -9.96 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.7 ttm180 83.01 78.58 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 39.67 51.17 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.144 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 8.6 mmtt 81.14 21.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.987 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.45 66.79 5.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.294 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -62.92 -22.49 73.86 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.68 2.253 . . . . 0.0 111.882 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.2 mp -43.16 -73.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.196 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -42.79 -27.17 0.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 10' ' ' THR . . . -77.76 -43.47 30.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 18.3 tt -74.02 -28.97 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.643 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HD2' ' CG2' ' A' ' 5' ' ' ILE . 2.9 mtpt -77.17 -34.84 56.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 7' ' ' ALA . 6.0 t -71.57 -30.59 66.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.53 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.6 t -78.52 -32.37 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.073 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.4 -31.17 76.25 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.739 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -85.49 -24.28 27.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.902 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -54.24 -24.42 18.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -109.94 7.13 23.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 2.0 m-30 -101.85 -24.31 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -98.09 48.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.057 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -136.41 44.18 0.97 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 72.9 Cg_endo -76.86 118.19 4.72 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.742 2.295 . . . . 0.0 112.145 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -77.09 -45.97 25.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.18 27.04 9.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 44.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -50.08 150.0 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.126 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mmmt . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.735 HD13 ' C ' ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.871 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 27' ' ' THR . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' C ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.952 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.952 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' THR . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.709 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.827 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 18' ' ' GLY . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' VAL . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 27' ' ' THR . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.687 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 27' ' ' THR . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' THR . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 17.4 mmtm . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.624 ' N ' HD23 ' A' ' 19' ' ' LEU . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.676 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.832 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 27' ' ' THR . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 1.5 t80 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.3 t80 . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 18' ' ' GLY . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.712 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 t80 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' THR . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.576 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.606 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.646 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.646 HG23 ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 4.6 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mmmp? . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 20' ' ' ARG . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.059 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.059 HG23 ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.787 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 27' ' ' THR . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 13.7 mttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.628 HD13 ' C ' ' A' ' 19' ' ' LEU . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.689 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.599 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 20' ' ' ARG . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.612 ' ND2' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.988 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' THR . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 19' ' ' LEU . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.769 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.769 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' CD ' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.638 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.902 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 3' ' ' ILE . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -56.27 82.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.352 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.95 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 1.8 tt -173.64 58.77 0.22 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.367 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 64.3 Cg_endo -93.15 -69.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.221 2.614 . . . . 0.0 112.309 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' CG2' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -51.49 -48.62 34.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.473 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.55 ' N ' ' CG2' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -68.45 -19.55 64.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 179.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.95 ' HB2' ' O ' ' A' ' 3' ' ' ILE . . . -76.17 -47.95 22.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.775 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -37.07 68.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 6.3 mmtp -68.54 -35.64 77.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.487 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -65.11 -45.54 84.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.357 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.701 ' O ' HG22 ' A' ' 15' ' ' VAL . 25.5 t -70.78 -37.65 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.957 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.23 -29.95 76.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.141 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.5 mmmt -72.3 -35.36 68.66 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 110.525 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -57.2 6.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -62.21 -29.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.205 179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.04 -43.21 73.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.235 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm -81.12 -26.96 35.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.0 110.498 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.3 -47.15 23.97 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.802 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 0.3 OUTLIER -65.51 -37.98 88.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 0.0 110.176 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -69.7 -43.95 71.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -51.29 -35.4 37.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.9 mt -76.29 -25.6 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.692 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.08 -54.69 6.71 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.785 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.48 -23.88 26.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.513 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -86.02 -23.84 26.64 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.774 178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.88 -38.51 22.82 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.336 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 31' ' ' VAL . 10.7 m -72.42 -34.01 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.77 -27.0 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.32 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.19 -73.42 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.58 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -42.03 18.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.334 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 27' ' ' THR . 62.3 t -64.6 -48.49 84.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.327 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -51.41 -22.0 2.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -107.95 -10.12 15.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.895 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 31' ' ' VAL . 17.7 t80 -72.96 -33.23 65.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.86 34.08 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.906 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.71 72.26 21.25 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.768 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.492 ' HB2' ' HG3' ' A' ' 39' ' ' LYS . 11.2 Cg_endo -54.14 177.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.081 2.521 . . . . 0.0 112.397 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' LYS . 3.3 mppt? -67.86 -12.3 60.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.962 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 25.2 mttt -35.19 -74.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER 77.41 -57.98 0.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.569 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' N ' ' CG ' ' A' ' 40' ' ' ARG . 0.3 OUTLIER -73.26 116.22 13.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.341 -0.838 . . . . 0.0 111.239 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.823 0.344 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -157.52 57.43 0.5 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.952 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.714 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 12.6 mm -136.84 -51.41 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.633 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 60.3 Cg_endo -97.54 -76.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 112.71 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.879 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -39.32 -63.31 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.199 0.523 . . . . 0.0 110.407 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.74 -22.83 25.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.637 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 3' ' ' ILE . . . -73.02 -42.49 63.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.879 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.7 tt -68.23 -33.39 60.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.276 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -77.61 -42.38 35.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.056 0.455 . . . . 0.0 109.869 179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 m -64.52 -32.68 74.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.684 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 7' ' ' ALA . 13.1 t -68.38 -44.29 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.495 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.6 -31.97 72.39 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.172 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -80.04 -29.27 39.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.823 0.344 . . . . 0.0 110.676 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.02 61.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -73.93 -40.57 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.955 0.407 . . . . 0.0 110.479 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.22 -37.5 86.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.085 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 -38.44 22.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.891 0.376 . . . . 0.0 110.654 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.92 -36.96 90.16 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.704 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.735 ' C ' HD13 ' A' ' 19' ' ' LEU . 2.5 tm? -72.08 -57.38 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.118 0.485 . . . . 0.0 110.567 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 5.7 tpp85 -59.43 -25.64 64.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.911 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.871 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -74.49 -32.78 62.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.946 0.403 . . . . 0.0 110.445 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' SER . 24.8 mt -70.86 -21.37 22.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.521 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.37 -64.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.464 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -55.08 -21.48 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.5 -26.54 28.05 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.218 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -89.82 -19.99 24.01 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.939 0.399 . . . . 0.0 110.56 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.3 m -85.13 -30.46 23.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.92 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.34 75.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.606 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -78.87 -57.13 3.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.467 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.54 -35.8 54.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.233 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.793 HG13 HD11 ' A' ' 35' ' ' LEU . 5.7 t -63.46 -57.63 11.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.269 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -39.49 -38.93 0.63 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.099 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -74.96 -45.07 44.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.595 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.717 ' HB3' HD23 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -63.6 -37.75 88.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.169 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.793 HD11 HG13 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -125.04 55.59 1.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.004 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.533 ' HG2' ' N ' ' A' ' 37' ' ' PRO . 4.6 tttt -78.72 -63.9 0.39 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.746 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.533 ' N ' ' HG2' ' A' ' 36' ' ' LYS . 77.9 Cg_endo -82.98 53.43 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.722 2.281 . . . . 0.0 112.398 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -22.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 -35.03 62.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER 57.73 178.24 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.575 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -149.37 -57.07 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.005 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.041 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' C ' HD13 ' A' ' 3' ' ' ILE . 15.0 mttp -107.25 -98.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.588 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -144.86 41.36 0.31 Allowed Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.569 0.224 . . . . 0.0 111.378 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 97.8 Cg_endo -82.03 -15.05 9.45 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.619 2.213 . . . . 0.0 112.72 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' ' CG1' ' A' ' 8' ' ' ILE . 3.4 mt -35.55 -77.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.763 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -40.71 -29.1 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.543 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.865 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -72.96 -44.55 60.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.534 ' CG1' ' O ' ' A' ' 5' ' ' ILE . 9.7 pt -66.99 -23.61 31.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.999 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 6' ' ' LYS . 3.2 mtmt -74.24 -44.29 53.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.898 0.38 . . . . 0.0 110.662 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -67.94 -31.62 71.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.237 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 7' ' ' ALA . 60.5 t -68.18 -46.6 80.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.727 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.55 -35.85 82.27 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.826 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 mmtt -81.81 -23.96 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.514 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -45.78 65.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.753 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -69.74 -36.07 68.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.209 179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -68.77 -37.46 84.26 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.086 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.6 mmtm -68.85 -35.76 77.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.803 0.335 . . . . 0.0 110.593 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.99 -44.56 97.2 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.007 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -61.1 -45.46 94.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.352 0.596 . . . . 0.0 110.476 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' C ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.14 -47.29 86.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.546 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' ' NE ' ' A' ' 20' ' ' ARG . . . -54.21 -30.91 51.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.169 0.509 . . . . 0.0 109.919 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 mt -77.75 -16.64 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.788 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.517 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -85.12 -55.65 3.94 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.102 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.952 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -54.19 -27.45 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.952 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.18 -32.01 30.13 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.718 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASN . 20.4 m -69.51 -34.83 74.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.986 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 19.4 m -69.67 -41.33 75.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.996 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.28 -36.69 68.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.725 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.16 -66.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.453 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -47.39 -30.78 3.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 27' ' ' THR . 40.4 t -70.82 -59.59 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -46.16 -34.19 4.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -79.74 -25.33 41.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.694 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.462 ' N ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.14 -31.62 72.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.816 179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.15 12.7 13.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.206 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' CB ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 mptp? -88.95 -59.01 0.25 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.0 110.761 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 36' ' ' LYS . 54.3 Cg_endo -89.96 30.69 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.08 2.52 . . . . 0.0 112.336 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.06 -73.74 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.005 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 39' ' ' LYS . 3.7 mmmt -97.54 -74.3 0.58 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER 179.07 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.048 0.451 . . . . 0.0 110.862 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 37' ' ' PRO . 21.6 mmmt 76.6 40.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.943 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.049 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.831 0.348 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' O ' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -112.59 -24.37 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.81 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.2 mp -86.64 -44.32 0.56 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.417 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 86.6 Cg_exo -47.93 -33.12 19.32 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.75 2.3 . . . . 0.0 112.646 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -72.51 -48.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.95 0.405 . . . . 0.0 110.798 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.591 ' N ' HG23 ' A' ' 5' ' ' ILE . 4.3 tptm -71.62 -18.41 62.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.153 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.5 -39.9 36.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.701 HD13 ' C ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -67.52 -36.76 77.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.357 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -63.86 -45.24 90.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.433 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 m -55.91 -39.41 71.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.343 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 15' ' ' VAL . 39.7 t -60.8 -49.51 84.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.297 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.64 -34.34 20.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.569 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -39.71 76.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 0.0 110.375 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 17' ' ' LYS . . . -65.39 -51.34 61.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.322 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 11' ' ' VAL . 10.1 t -58.34 -27.44 32.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.001 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.29 -56.18 8.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.774 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -61.55 -28.04 69.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.87 -27.81 71.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.491 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.709 ' C ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -69.22 -48.83 60.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.4 tpp85 -48.65 -57.57 6.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.421 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.827 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -50.58 -36.8 36.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.586 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 19' ' ' LEU . 35.4 mt -69.64 -14.78 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.956 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -78.92 -63.69 1.36 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.41 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.28 -22.21 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.67 -25.05 28.72 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.553 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -26.81 57.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.403 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 31' ' ' VAL . 8.0 m -88.77 -25.83 22.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.722 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.38 -29.01 56.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.033 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.1 p30 -71.11 -43.67 67.17 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.918 0.389 . . . . 0.0 110.422 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 21.8 t70 -65.23 -41.63 94.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.837 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 27' ' ' THR . 40.0 t -63.33 -48.18 88.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.021 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' O ' ' HG2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -46.24 -42.07 13.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.882 179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.81 -33.0 25.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.154 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -16.56 20.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.363 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -162.51 91.46 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.8 0.333 . . . . 0.0 111.105 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -123.62 -66.23 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.393 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' CG ' ' A' ' 36' ' ' LYS . 61.7 Cg_endo -85.63 -172.28 1.08 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.392 2.061 . . . . 0.0 112.54 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.69 6.0 9.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ARG . 24.7 mtmt -63.38 -74.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.85 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 39' ' ' LYS . 7.0 ttm180 73.18 135.89 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.55 -18.42 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.129 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.841 0.353 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.771 ' O ' HD11 ' A' ' 5' ' ' ILE . 2.0 mptp? -160.38 -57.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.178 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.528 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 7.0 mt -87.67 -58.62 0.28 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 36.7 Cg_endo -65.7 -18.43 58.53 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.492 2.128 . . . . 0.0 113.411 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.955 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -47.11 -73.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.131 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.4 tptm -50.25 -23.41 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.908 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -74.05 -43.78 56.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.955 HG22 ' O ' ' A' ' 5' ' ' ILE . 20.5 tt -65.86 -23.56 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.859 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 17.7 mmtp -74.6 -46.92 35.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.585 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 m -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG13 ' CG2' ' A' ' 15' ' ' VAL . 27.1 t -75.91 -24.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.973 0.416 . . . . 0.0 110.367 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.23 -27.37 70.15 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.67 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 20.3 mmtt -85.29 -36.09 21.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.684 0.278 . . . . 0.0 110.815 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.87 -48.36 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 110.417 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.534 ' CG2' HG13 ' A' ' 11' ' ' VAL . 23.8 t -77.21 -20.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.022 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.46 -31.01 42.75 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.994 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -43.81 44.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.81 -34.88 89.96 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.63 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.766 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.7 OUTLIER -62.66 -45.31 93.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.665 0.269 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -61.59 -52.3 64.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.078 0.466 . . . . 0.0 110.246 179.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.21 -29.8 4.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.811 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 18' ' ' GLY . 4.4 mm -79.43 -25.5 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.35 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER -79.72 -48.63 13.32 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.631 0.729 . . . . 0.0 109.841 179.25 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.505 ' HA ' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -56.6 -33.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.378 178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.32 -16.81 47.95 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.088 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.48 ' HB2' ' HA ' ' A' ' 23' ' ' ASN . 1.2 m -86.72 -29.03 22.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.674 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' VAL . 75.8 m -79.6 -35.33 39.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.493 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.42 -26.29 62.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.882 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -57.24 8.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -29.58 68.33 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 27' ' ' THR . 93.8 t -74.22 -48.63 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.793 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.27 -18.99 65.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.396 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.493 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 24.4 t-20 -89.54 -32.22 17.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.607 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -26.0 62.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.681 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' ' C ' ' A' ' 36' ' ' LYS . 2.5 mm? -78.49 -84.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.848 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' C ' ' O ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER 17.83 65.32 0.22 Allowed Pre-proline 0 N--CA 1.466 0.337 0 O-C-N 123.744 0.653 . . . . 0.0 112.041 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 19.0 Cg_endo -59.94 111.99 1.15 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.729 2.286 . . . . 0.0 111.955 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.82 41.09 5.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 46.0 mmtm 40.81 32.14 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 71.57 -59.56 0.55 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.68 7.82 3.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.133 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.811 0.339 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -100.24 145.45 28.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.873 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.584 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 1.6 mt -88.84 -41.85 0.45 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.674 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 91.5 Cg_endo -82.39 -3.29 11.4 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.706 2.271 . . . . 0.0 112.828 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.543 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -53.56 -37.76 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.068 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.8 -32.4 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.63 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.57 -35.63 68.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.2 tt -71.27 -34.75 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.764 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.5 mmtt -73.87 -28.75 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.836 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HG2' ' A' ' 13' ' ' LYS . 3.1 m -73.4 -34.22 65.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.952 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.94 -34.53 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.722 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.86 -34.12 62.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.754 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 10' ' ' THR . 0.5 OUTLIER -78.69 -30.35 46.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.317 . . . . 0.0 111.094 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.87 -47.05 61.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.951 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.62 -24.8 21.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.681 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.27 -27.94 54.26 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.305 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -84.84 -37.98 20.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.864 0.364 . . . . 0.0 110.61 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -65.09 -41.48 97.09 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.024 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.34 -43.44 41.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.482 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 1.2 tpp180 -63.5 -47.78 80.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.672 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -62.19 -36.51 82.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.698 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 18' ' ' GLY . 62.2 mt -69.14 -19.43 23.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.505 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -77.07 -64.87 1.03 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.664 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.3 pp -54.91 -22.39 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.206 -0.906 . . . . 0.0 108.854 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -89.24 -24.44 22.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.452 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.8 m -83.48 -33.9 25.48 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 31' ' ' VAL . 18.5 m -75.97 -37.9 58.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.28 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 32' ' ' PHE . . . -68.13 -23.71 64.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.01 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.488 ' CG ' ' N ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -75.35 -59.39 2.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.463 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.488 ' N ' ' CG ' ' A' ' 29' ' ' ASN . 34.5 t0 -59.68 -37.34 78.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.178 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 27' ' ' THR . 93.9 t -72.4 -45.71 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.435 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.514 ' CB ' ' O ' ' A' ' 28' ' ' ALA . 45.8 t80 -51.62 -30.78 22.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.642 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.459 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 1.4 t-20 -77.89 -41.49 36.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.632 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -80.86 4.41 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.784 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' A' ' 37' ' ' PRO . 20.3 tp -144.34 65.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' ASN . 5.0 pttm -117.28 60.88 2.87 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.23 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.0 Cg_exo -40.76 -45.9 4.79 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.767 2.311 . . . . 0.0 112.531 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm -41.88 -42.08 2.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.272 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.27 -18.38 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -72.35 107.05 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.071 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -80.0 102.4 9.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.998 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.849 0.357 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.55 75.12 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.741 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 3' ' ' ILE . 35.0 mt 60.09 52.28 3.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.047 0.451 . . . . 0.0 110.616 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 57.8 Cg_endo -70.97 -13.49 31.67 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.128 2.552 . . . . 0.0 112.72 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.791 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.9 mt -46.37 -48.33 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.901 0.381 . . . . 0.0 110.702 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HG3' HG22 ' A' ' 3' ' ' ILE . 6.4 mttt -58.21 -20.72 43.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.555 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -73.03 -50.49 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.884 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 5' ' ' ILE . 19.6 tt -61.02 -29.56 45.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.897 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.94 -40.39 75.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.531 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -59.45 -40.05 85.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.418 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -67.27 -54.42 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.348 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.05 -23.92 60.06 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.559 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -84.07 -27.21 28.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.524 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.03 -53.9 13.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.09 -32.9 59.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.453 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.86 -28.51 64.73 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.088 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -82.34 -36.12 27.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.402 . . . . 0.0 110.425 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.32 -40.99 99.59 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.473 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.528 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER -73.13 -45.33 57.44 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.226 0.536 . . . . 0.0 110.412 179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.687 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -61.32 -50.84 71.32 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB2' ' NH2' ' A' ' 20' ' ' ARG . . . -54.85 -36.3 64.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 109.781 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 22' ' ' ILE . 24.6 mt -71.55 -11.46 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -79.99 -60.39 2.36 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.825 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -63.7 -24.62 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -81.01 -28.73 35.37 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.302 178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.5 m -73.64 -49.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.175 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.4 m -66.84 -29.87 69.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.42 67.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.497 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 25' ' ' ALA . 10.8 m120 -54.66 -76.99 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.7 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -43.01 -35.83 1.37 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.756 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 27' ' ' THR . 66.8 t -65.48 -47.68 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.917 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -62.75 -30.83 71.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.806 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -87.83 -8.27 56.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.995 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.55 -34.37 19.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.205 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.02 77.66 1.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.178 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -124.66 48.75 2.67 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 58.6 Cg_endo -73.57 -35.74 4.45 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.798 2.332 . . . . 0.0 112.496 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER 84.53 -42.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.324 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -29.94 -56.72 0.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.605 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.73 136.84 39.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.218 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -78.84 78.6 5.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.456 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.326 -179.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.761 0.315 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' C ' HG12 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -148.77 -80.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.186 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.534 HG13 ' CD ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -153.96 -67.18 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.204 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' CD ' HG13 ' A' ' 3' ' ' ILE . 36.8 Cg_endo -66.26 -17.03 53.7 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.806 2.337 . . . . 0.0 113.255 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 6' ' ' LYS . 2.5 pp -54.51 -43.81 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.861 0.363 . . . . 0.0 111.355 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.816 ' N ' HD12 ' A' ' 5' ' ' ILE . 13.0 pttm -67.08 -16.59 64.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.583 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -77.51 -47.03 20.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.922 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.8 tt -66.21 -33.06 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.628 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -39.35 77.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.567 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.7 m -61.36 -38.59 87.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.425 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.8 t -70.52 -39.91 76.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.63 -29.25 72.81 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.499 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -83.43 -27.8 29.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.341 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -72.28 -46.43 55.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.694 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.96 -34.61 65.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.311 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.41 -35.98 69.18 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.281 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 6.8 pttp -71.85 -28.14 63.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 110.533 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -65.56 -56.79 13.29 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.706 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -54.66 -38.32 66.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.992 0.425 . . . . 0.0 110.076 179.366 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -67.45 -35.99 80.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.32 -19.04 65.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.092 0.472 . . . . 0.0 109.744 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 18' ' ' GLY . 7.0 mm -80.33 -37.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.312 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 20' ' ' ARG . 1.3 p-10 -76.52 -46.45 26.53 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.542 0.687 . . . . 0.0 109.64 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 24' ' ' ILE . 0.5 OUTLIER -55.54 -33.47 32.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.06 177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.37 58.07 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.437 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.3 OUTLIER -79.98 -32.43 39.78 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.48 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 31' ' ' VAL . 3.3 m -73.83 -32.36 63.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.757 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.6 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 30' ' ' ASP . 1.4 p30 -65.11 -38.56 91.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.196 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 33.3 t70 -69.64 -28.23 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.018 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 27' ' ' THR . 36.3 t -73.95 -54.17 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.369 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -61.07 -24.74 66.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.648 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -79.69 -45.28 19.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.625 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.3 -28.87 45.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.089 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 15.0 tp -98.49 -7.77 27.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.255 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -59.01 -49.76 91.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 91.2 Cg_endo -79.23 91.36 1.2 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.606 2.204 . . . . 0.0 112.532 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -71.36 -14.61 62.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -9.53 21.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 41' ' ' LYS . 0.1 OUTLIER 72.83 -67.16 0.28 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.977 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.675 ' O ' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -37.63 136.42 0.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.821 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.092 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -171.01 44.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.701 HG22 ' HD3' ' A' ' 4' ' ' PRO . 4.8 tt -94.67 -30.28 0.28 Allowed Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.701 ' HD3' HG22 ' A' ' 3' ' ' ILE . 67.8 Cg_endo -76.38 -25.01 10.2 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.846 1.698 . . . . 0.0 113.068 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.5 mt -60.57 -66.26 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.061 0.457 . . . . 0.0 110.572 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -58.65 -21.65 54.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.327 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' O ' HG22 ' A' ' 11' ' ' VAL . . . -76.71 -44.03 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.1 tt -68.7 -26.63 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 6' ' ' LYS . 6.6 mttm -75.13 -39.23 60.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -41.76 83.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.223 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 8' ' ' ILE . 14.3 m -67.09 -44.6 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.453 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 11' ' ' VAL . . . -61.64 -37.84 94.89 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.414 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 17.4 mmtm -73.71 -24.0 59.86 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.38 -53.33 20.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.503 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -58.21 -36.25 56.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.34 -36.93 85.52 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.924 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -75.32 -32.74 61.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.837 0.351 . . . . 0.0 110.416 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 21' ' ' ALA . . . -62.74 -48.97 77.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.584 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -60.26 -49.98 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.302 0.572 . . . . 0.0 109.963 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.624 ' N ' HD23 ' A' ' 19' ' ' LEU . 11.0 tpp180 -61.23 -33.11 72.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.907 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' GLY . . . -59.44 -33.19 70.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.641 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mt -72.32 -25.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.676 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -72.38 -63.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.241 179.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -54.66 -22.03 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -82.93 -30.06 28.68 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.483 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -75.06 -31.16 61.18 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.905 179.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.832 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.0 m -71.27 -41.55 69.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.141 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.9 -29.04 62.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.595 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 7.7 m120 -56.73 -70.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.512 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -49.76 -35.55 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 27' ' ' THR . 26.1 t -64.58 -45.96 93.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.509 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.506 ' C ' ' CD1' ' A' ' 32' ' ' PHE . 1.5 t80 -53.52 -32.58 51.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.447 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -77.54 -39.82 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.628 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -69.16 -12.53 61.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 35' ' ' LEU . 46.1 tp -92.72 5.07 52.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.836 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -120.62 72.13 20.45 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 165.72 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.831 2.354 . . . . 0.0 112.104 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tptt -47.99 -28.42 2.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 45.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.933 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -65.29 114.47 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -82.33 177.84 8.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.726 179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 41' ' ' LYS . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.834 0.35 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -100.39 23.41 10.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 3' ' ' ILE . 6.9 mm 62.04 52.68 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.639 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.638 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 33.7 Cg_endo -65.07 -24.14 60.01 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.762 2.308 . . . . 0.0 112.367 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.83 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -37.28 -69.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.875 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -38.4 -35.36 0.17 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.74 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -62.48 -54.28 42.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 5' ' ' ILE . 12.5 tt -60.7 -16.23 12.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.688 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mmmt -82.47 -32.2 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.767 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 58.9 m -71.1 -35.54 71.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.558 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.494 ' CG1' ' N ' ' A' ' 12' ' ' GLY . 2.4 p -75.24 -45.17 41.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.257 0.551 . . . . 0.0 110.082 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -68.14 -29.59 73.43 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.528 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -78.66 -28.63 45.4 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.77 0.319 . . . . 0.0 110.725 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.7 -48.23 55.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.774 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.36 -30.99 50.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.782 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.16 -35.65 57.01 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.107 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -37.55 70.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.853 0.359 . . . . 0.0 110.853 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.03 94.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.091 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -59.68 -40.73 88.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.824 0.345 . . . . 0.0 110.555 179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -63.79 -39.12 93.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.526 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.68 -35.88 68.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.218 0.532 . . . . 0.0 109.6 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -75.15 -21.04 16.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.635 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -77.29 -57.26 3.93 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.64 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.86 -20.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.61 -27.04 31.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.642 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.43 -24.19 21.94 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.9 m -86.75 -27.97 23.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.185 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.67 -23.18 56.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.645 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -58.24 -72.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.805 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -42.75 -35.71 1.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.52 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.48 -50.87 47.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.024 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 5.3 t80 -47.78 -25.38 1.24 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.522 ' HA ' ' CD ' ' A' ' 36' ' ' LYS . 3.3 t30 -90.14 -30.64 17.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.82 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.47 -40.42 95.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.186 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.401 ' C ' ' HD2' ' A' ' 37' ' ' PRO . 0.6 OUTLIER -110.32 45.76 1.09 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.127 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.559 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -48.07 -47.33 65.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.126 0.489 . . . . 0.0 110.746 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 90.5 Cg_endo -83.11 -94.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.854 2.37 . . . . 0.0 112.209 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER -175.16 44.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.862 0.363 . . . . 0.0 110.87 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 59.48 22.27 10.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 65.18 10.12 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -60.42 176.97 0.31 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.83 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.111 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' C ' HD11 ' A' ' 5' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.782 0.325 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.524 ' CB ' ' HD2' ' A' ' 4' ' ' PRO . 5.3 mttp -61.6 -172.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.897 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.74 ' N ' HD13 ' A' ' 3' ' ' ILE . 1.4 mm -84.12 -40.58 0.73 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.699 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 72.5 Cg_exo -41.44 -64.68 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.655 2.236 . . . . 0.0 112.871 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.918 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -32.54 -67.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.611 -179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 3' ' ' ILE . 13.0 ptpt -57.42 -29.23 63.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -71.78 -34.73 69.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.077 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.918 HG22 ' O ' ' A' ' 5' ' ' ILE . 17.7 tt -77.54 -27.7 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.557 ' HE3' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -74.95 -29.0 60.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.357 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.7 m -74.06 -43.18 58.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.238 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.707 ' O ' HG22 ' A' ' 15' ' ' VAL . 93.7 t -70.86 -42.61 77.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.289 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.52 -31.51 78.94 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.28 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -81.43 -24.43 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 110.284 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -51.33 28.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.468 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.707 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -63.99 -37.1 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.278 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.13 -35.39 91.67 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.122 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -78.52 -46.18 20.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.92 0.39 . . . . 0.0 110.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -59.41 -41.5 97.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.94 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 tp -66.31 -46.83 75.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.117 0.484 . . . . 0.0 110.316 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -56.98 -44.27 82.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.699 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.84 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -62.11 -32.32 72.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.303 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 18' ' ' GLY . 34.6 mm -72.85 -20.53 19.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.127 0.489 . . . . 0.0 109.869 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.495 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -79.43 -63.26 1.46 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.748 179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.84 HD12 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -58.01 -21.4 16.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.712 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -83.45 -26.2 30.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.654 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.15 -43.95 15.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.188 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.3 m -73.11 -27.02 61.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.856 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 24' ' ' ILE . . . -68.5 -27.82 66.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.659 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.04 -69.24 0.14 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.663 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -47.36 -44.22 23.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.506 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' THR . 59.4 t -59.75 -38.0 73.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.466 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.529 ' O ' HD23 ' A' ' 35' ' ' LEU . 3.5 t80 -65.84 -22.2 66.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -91.02 -22.64 20.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -77.01 -28.59 55.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -89.08 -3.78 58.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.968 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.26 60.71 38.06 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 121.298 0.571 . . . . 0.0 111.056 -179.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 94.1 Cg_endo -87.0 40.57 0.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.099 2.533 . . . . 0.0 112.262 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 39' ' ' LYS . 1.5 mmtt -52.33 -20.43 2.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.639 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -136.87 5.32 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.623 0.249 . . . . 0.0 111.563 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 48.58 -172.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.761 0.315 . . . . 0.0 110.691 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -42.68 -52.68 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.059 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.824 0.345 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 -41.87 0.15 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.066 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -157.96 51.01 0.44 Allowed Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.611 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 98.1 Cg_endo -80.32 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.801 2.334 . . . . 0.0 112.406 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.001 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.3 mt -51.45 -66.4 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.93 0.395 . . . . 0.0 110.92 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.12 -30.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.721 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -66.24 -43.23 87.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.719 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.001 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.2 tt -67.9 -21.32 26.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.519 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.35 -45.34 60.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 94.3 m -66.53 -45.03 80.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.051 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.765 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.4 p -66.27 -41.37 88.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.875 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' N ' ' CG1' ' A' ' 11' ' ' VAL . . . -59.26 -41.07 96.62 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.863 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -59.29 -41.86 89.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.041 0.448 . . . . 0.0 110.133 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 17' ' ' LYS . . . -67.45 -29.29 68.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.315 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 11' ' ' VAL . 55.9 t -68.43 -38.67 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.368 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' A' ' 19' ' ' LEU . . . -63.8 -45.48 94.2 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.828 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ALA . 8.4 pttp -67.71 -23.35 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.257 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.03 -52.4 41.95 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.149 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -61.78 -37.7 85.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.078 0.466 . . . . 0.0 110.284 179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -73.54 -23.83 60.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.767 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' O ' ' CD1' ' A' ' 24' ' ' ILE . . . -67.34 -35.23 78.98 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.587 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 23.4 mm -70.46 -33.5 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -63.83 -61.78 2.07 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.457 179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.8 pp -51.9 -24.23 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -78.23 -31.46 49.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.599 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.954 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -69.29 -43.02 74.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.87 179.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.0 -26.71 38.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.115 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -55.31 14.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.986 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -54.83 -36.15 64.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.581 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' THR . 96.2 t -55.11 -44.5 74.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.056 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -38.74 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.083 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.469 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 5.6 m-80 -71.34 -18.04 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.636 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -83.71 -24.87 31.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.609 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' C ' ' HG2' ' A' ' 36' ' ' LYS . 56.7 tp -104.33 -51.92 3.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.673 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HD3' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER 30.54 92.67 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.354 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.67 -160.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.572 2.181 . . . . 0.0 112.064 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HB2' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.49 41.64 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.232 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp 42.23 56.14 3.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' HD3' ' HB2' ' A' ' 38' ' ' LYS . 3.0 ptm180 -156.56 21.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -126.11 59.84 1.31 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.812 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.164 -179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.763 0.316 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -103.0 -6.93 21.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.026 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.562 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 2.7 mp -84.45 -44.32 0.73 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 91.3 Cg_endo -84.09 20.05 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.89 2.394 . . . . 0.0 112.539 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' O ' HG13 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -43.46 -84.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.21 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -36.39 -31.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.747 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -63.69 -52.27 61.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.063 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -59.85 -22.54 24.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -45.49 35.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' CG ' ' A' ' 13' ' ' LYS . 3.9 m -65.88 -23.94 66.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 7' ' ' ALA . 61.4 t -75.3 -47.1 36.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.553 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.83 -35.39 86.46 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.617 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' CG ' ' HA ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -78.92 -26.79 43.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 0.0 110.488 179.502 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.06 -51.44 54.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.632 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -63.34 -36.55 76.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.358 179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.53 -31.3 80.29 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.132 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -48.23 65.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.941 0.4 . . . . 0.0 110.826 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.12 67.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.17 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 tp -64.04 -47.18 81.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.128 0.49 . . . . 0.0 110.548 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.576 ' CD ' ' ND2' ' A' ' 23' ' ' ASN . 12.1 tpp85 -57.44 -34.62 69.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.606 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -65.13 -40.45 94.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.764 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.9 mt -66.4 -20.68 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.646 ' ND2' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -66.33 -62.87 1.24 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.629 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.646 HG23 ' ND2' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -54.07 -26.99 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -77.79 -27.66 50.27 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.658 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.469 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -70.06 -44.27 69.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.231 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.03 -43.25 95.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.249 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.5 -22.47 32.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.644 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 8.7 m120 -71.18 -59.46 2.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.671 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -56.18 -39.46 72.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.127 0.489 . . . . 0.0 110.194 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.39 -48.02 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.605 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CD1' ' O ' ' A' ' 32' ' ' PHE . 4.6 t80 -59.64 -34.26 72.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.696 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -72.57 -26.81 61.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' C ' HD23 ' A' ' 35' ' ' LEU . 10.6 m-85 -74.31 -30.2 61.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.564 HD23 ' C ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -137.6 82.3 1.92 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.091 0.472 . . . . 0.0 111.018 179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 57.73 5.0 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.841 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 35' ' ' LEU . 72.5 Cg_endo -77.05 168.37 23.45 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.755 2.303 . . . . 0.0 112.529 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -80.1 -10.82 59.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -97.8 0.23 46.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.041 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER 67.94 162.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.666 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt 67.29 -176.11 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.128 179.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.865 0.364 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.9 3.33 9.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.865 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.624 ' N ' HD13 ' A' ' 3' ' ' ILE . 0.8 OUTLIER -87.82 -44.95 0.49 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.129 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 3' ' ' ILE . 78.4 Cg_exo -50.32 -25.59 14.01 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.804 2.336 . . . . 0.0 112.604 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.67 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -57.93 -49.63 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.084 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' N ' HG23 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -60.07 -30.32 69.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.448 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -64.17 -44.69 91.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.277 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 5' ' ' ILE . 1.3 tt -61.4 -39.15 81.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -39.2 93.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.5 m -61.77 -41.27 97.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.531 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 7' ' ' ALA . 24.9 t -57.97 -48.49 84.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.757 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.2 -37.51 64.64 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.245 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mmmp? -71.57 -33.62 69.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.186 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.8 -56.53 15.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.049 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -57.86 -36.49 55.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.099 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . -60.45 -41.54 98.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.03 -25.67 58.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.912 0.387 . . . . 0.0 110.348 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.68 -53.09 48.94 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.987 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 HD12 ' N ' ' A' ' 20' ' ' ARG . 2.8 pp -63.65 -49.87 71.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.189 0.519 . . . . 0.0 110.351 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -49.27 -45.84 45.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -56.75 -33.0 66.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.741 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 10.8 mt -71.87 -11.96 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.486 178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -79.01 -59.96 2.57 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.783 179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -61.05 -23.66 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.43 -25.07 25.43 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.833 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -76.15 -37.2 58.25 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.947 179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.059 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.2 m -72.92 -36.27 67.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.852 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.12 -35.02 74.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.859 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.45 -47.46 73.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.241 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -65.13 -36.07 83.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.887 179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.059 HG23 ' O ' ' A' ' 27' ' ' THR . 55.5 t -57.68 -41.56 79.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.266 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -63.35 -42.35 98.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.068 179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -53.06 -31.7 42.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 109.869 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' HD3' ' A' ' 36' ' ' LYS . 80.5 t80 -73.68 -33.89 64.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.212 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -89.57 -23.08 22.07 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.868 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' PHE . 0.0 OUTLIER 39.58 101.23 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.365 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 12.4 Cg_endo -55.47 -70.49 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.802 2.334 . . . . 0.0 111.828 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.1 -170.57 2.95 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.293 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -83.21 46.66 1.15 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.073 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.39 121.03 16.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.756 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -89.79 107.47 19.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.247 -0.883 . . . . 0.0 111.107 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' HB1' ' CG ' ' A' ' 4' ' ' PRO . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.909 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.612 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -138.04 39.87 0.42 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.752 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 66.1 Cg_endo -85.52 24.21 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.613 2.209 . . . . 0.0 112.353 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.681 ' O ' HD13 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -41.07 -44.4 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.541 -179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' N ' HG23 ' A' ' 5' ' ' ILE . 36.5 mmtt -66.86 -28.59 68.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.935 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 11' ' ' VAL . . . -74.83 -44.68 47.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.912 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 5' ' ' ILE . 16.4 pt -67.09 -20.16 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -77.82 -47.91 17.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.581 179.684 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' A' ' 9' ' ' LYS . 32.5 m -66.74 -34.31 77.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.186 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 7' ' ' ALA . 94.6 t -71.56 -45.87 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.551 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.53 -23.58 66.97 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.184 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -80.82 -32.17 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 110.356 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 -53.56 41.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -63.74 -35.07 71.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.427 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.22 -32.33 81.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.972 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -42.43 70.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.397 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.66 -52.98 47.14 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.563 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 19' ' ' LEU . 1.6 tm? -55.56 -47.77 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.084 0.469 . . . . 0.0 110.226 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 10.5 tpp85 -55.84 -45.29 78.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.469 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 24' ' ' ILE . . . -55.57 -28.11 53.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.055 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 13.1 mm -76.97 -21.61 14.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.17 -63.64 1.23 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.299 179.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.787 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -57.95 -25.55 26.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.787 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -78.9 -28.3 43.98 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.574 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.49 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 58.2 m -85.04 -15.59 43.57 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -79.54 -40.3 29.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 179.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.81 -36.26 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.55 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 26' ' ' SER . 1.0 OUTLIER -77.93 -51.66 10.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.262 179.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -58.56 -24.72 61.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.015 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 27' ' ' THR . 18.3 t -78.21 -58.74 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.536 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -24.43 0.48 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.778 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 12.9 t-20 -91.82 -33.08 15.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.221 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 1.7 t80 -61.58 -35.38 77.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.016 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.12 67.41 0.83 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.008 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 10.5 mttt -90.01 -48.69 0.38 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 36' ' ' LYS . 64.5 Cg_endo -87.34 -175.97 1.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.742 2.294 . . . . 0.0 112.441 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.8 ptmt -133.7 -37.13 0.93 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.066 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.35 1.58 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 37' ' ' PRO . 14.7 ttm-85 -160.49 95.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.969 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -71.11 102.14 2.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.755 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.08 -179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -138.67 -60.76 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.603 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.518 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 1.1 tt -154.43 53.36 0.89 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.919 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 97.0 Cg_endo -85.69 7.36 5.1 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.875 2.383 . . . . 0.0 112.814 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -61.55 -73.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.343 . . . . 0.0 111.086 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -25.49 12.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.52 -44.12 45.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.232 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.71 HG22 ' O ' ' A' ' 5' ' ' ILE . 3.4 tt -69.13 -28.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.7 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD2' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.6 -35.69 57.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.522 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.4 m -69.45 -38.33 77.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.446 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 53.4 t -70.69 -42.11 77.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.558 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.75 75.74 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.599 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 13.7 mttt -81.69 -28.79 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 -45.0 77.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.994 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.4 m -68.38 -42.87 84.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.768 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.16 -29.41 68.72 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.039 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -79.92 -36.78 35.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.854 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.68 -49.12 71.19 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.013 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.628 ' C ' HD13 ' A' ' 19' ' ' LEU . 2.1 tm? -63.32 -40.82 98.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.684 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -65.58 -40.24 92.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.597 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.689 ' O ' HD13 ' A' ' 24' ' ' ILE . . . -54.4 -38.9 66.73 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.2 mt -73.82 -21.15 18.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.503 178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -76.32 -56.38 4.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.566 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.6 -21.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.044 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.599 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -87.5 -28.1 22.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.362 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -84.19 -26.7 28.57 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.969 0.414 . . . . 0.0 110.444 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.776 ' O ' HG23 ' A' ' 31' ' ' VAL . 33.2 m -79.55 -38.55 33.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.132 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.15 79.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.676 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -80.51 -49.16 11.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.986 0.422 . . . . 0.0 110.258 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -60.04 -35.59 75.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.87 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 27' ' ' THR . 9.6 t -61.53 -55.39 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.462 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -64.91 -15.74 62.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.98 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.472 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 6.8 t30 -89.62 -32.57 17.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.034 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -66.55 -42.72 86.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.0 111.045 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.474 ' HG ' ' N ' ' A' ' 36' ' ' LYS . 4.3 tp -67.29 -80.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.622 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' N ' ' HG ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 39.11 94.95 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.77 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.37 142.75 41.71 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.697 2.265 . . . . 0.0 111.788 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -90.73 -49.02 6.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.376 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 40' ' ' ARG . 3.0 mttm -96.58 6.21 49.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.328 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 35.44 66.1 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.921 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 40' ' ' ARG . 10.1 mmtt -36.99 141.71 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.06 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.921 0.391 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.486 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 0.5 OUTLIER -97.14 -166.74 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.854 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.803 ' O ' HG22 ' A' ' 3' ' ' ILE . 40.9 mt 71.52 44.85 0.22 Allowed Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.622 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 83.5 Cg_endo -83.74 -4.08 10.64 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.742 2.295 . . . . 0.0 112.51 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -43.93 -37.09 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -24.41 65.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.01 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 4' ' ' PRO . . . -76.5 -40.15 51.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -66.32 -36.91 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.838 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.8 OUTLIER -65.87 -42.44 90.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.61 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -60.05 -40.75 90.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.553 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 7' ' ' ALA . 98.7 t -66.45 -37.18 79.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.699 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.85 -28.78 70.76 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.519 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' O ' ' CG ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -80.82 -36.97 30.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.798 0.332 . . . . 0.0 110.451 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.02 -53.93 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.214 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.86 -24.43 30.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.936 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.94 -32.79 69.9 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.76 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 1.6 mmmm -73.25 -52.89 12.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -63.31 -31.77 81.87 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.304 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -47.7 72.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.097 0.475 . . . . 0.0 110.329 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ARG . 10.0 tpp85 -60.71 -28.44 68.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.235 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.43 -21.5 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' GLY . 17.4 mm -75.16 -26.7 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.589 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.612 ' ND2' HG22 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -74.79 -61.29 1.93 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.558 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.988 HD13 ' N ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -54.36 -26.0 14.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.988 ' N ' HD13 ' A' ' 24' ' ' ILE . . . -82.77 -26.47 31.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.034 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -77.18 -31.96 55.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.17 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 m -70.23 -46.69 63.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.427 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 31' ' ' VAL . . . -67.75 -28.47 67.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.562 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.75 -59.89 3.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.452 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.89 -39.07 62.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.129 179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 27' ' ' THR . 26.9 t -57.01 -42.86 79.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.699 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -61.38 -43.96 97.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.836 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 36' ' ' LYS . 18.3 t-20 -67.07 -21.56 65.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.82 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.63 -40.58 66.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.092 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 36' ' ' LYS . 7.1 mt -100.99 -29.1 12.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.6 OUTLIER 35.56 58.99 2.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.056 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 36' ' ' LYS . 25.0 Cg_exo -63.07 102.12 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.274 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -56.42 -36.66 69.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.585 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.58 28.69 1.61 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 57.66 174.77 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.25 148.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.654 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.988 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 1.4 mttm -72.91 -146.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.591 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.567 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 mm -129.36 48.01 3.32 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-O 120.563 0.221 . . . . 0.0 111.539 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.567 ' HD3' ' N ' ' A' ' 3' ' ' ILE . 76.4 Cg_exo -49.01 -27.02 11.13 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.235 1.956 . . . . 0.0 112.115 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.1 pp -61.81 -35.53 68.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -72.83 -25.47 61.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.169 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 11' ' ' VAL . . . -70.86 -39.43 72.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 5' ' ' ILE . 0.7 OUTLIER -73.21 -34.72 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.726 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 1.0 OUTLIER -70.37 -35.54 73.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.59 179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.0 m -67.32 -45.4 76.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 12' ' ' GLY . 17.0 m -70.34 -44.7 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.317 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 11' ' ' VAL . . . -66.41 -26.41 72.72 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.399 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 15.8 mmtt -84.25 -19.93 33.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.245 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 -46.21 62.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.697 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.74 -42.39 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.164 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -70.06 -30.63 69.73 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.888 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -70.99 -35.08 71.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.903 0.382 . . . . 0.0 110.414 179.604 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.83 39.23 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.669 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 19' ' ' LEU . 1.1 pp -71.74 -39.07 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.283 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' GLY . 2.9 tpp180 -61.12 -37.38 82.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.158 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.95 91.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.232 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -67.67 -17.77 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -75.44 -64.26 1.11 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.3 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.769 HD12 ' N ' ' A' ' 25' ' ' ALA . 2.7 pp -50.61 -25.34 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.769 ' N ' HD12 ' A' ' 24' ' ' ILE . . . -84.85 -29.32 25.39 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.094 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' ASN . 3.3 m -78.31 -22.39 48.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.325 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.8 m -79.1 -47.05 16.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.562 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 32' ' ' PHE . . . -70.24 -21.11 63.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.609 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -73.78 -71.38 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' CG ' ' A' ' 34' ' ' PHE . 1.5 m-20 -40.65 -36.95 0.66 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.318 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.1 t -69.62 -57.54 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.477 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -51.67 -31.74 26.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.277 179.563 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.39 -28.16 41.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.59 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CG ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m-30 -76.1 -28.67 57.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.463 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.21 -66.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.59 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.5 92.61 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.143 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . 25.9 Cg_exo -62.14 163.68 19.21 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.698 2.265 . . . . 0.0 112.007 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 39' ' ' LYS . 1.3 pttm -63.85 72.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 34.8 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.5 mtt85 -112.49 88.67 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -133.21 -70.56 0.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.22 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.498 ' HG2' HG13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -118.89 -20.84 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 4' ' ' PRO . 1.5 mt -95.86 -47.63 0.25 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.244 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HD3' ' HB ' ' A' ' 3' ' ' ILE . 96.5 Cg_endo -89.49 24.37 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.978 2.452 . . . . 0.0 112.502 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 6' ' ' LYS . 11.6 pt -49.78 -48.62 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.44 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' N ' HG13 ' A' ' 5' ' ' ILE . 1.6 mmtt -60.12 -23.72 64.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.709 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 4' ' ' PRO . . . -74.02 -40.66 62.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -64.13 -38.63 82.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.06 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 2.0 mmtt -67.38 -38.31 84.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.25 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 m -57.68 -40.97 80.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.5 t -63.6 -48.39 87.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.789 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.1 -25.47 56.98 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.959 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 9' ' ' LYS . 2.5 mttp -82.63 -35.17 27.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.821 0.343 . . . . 0.0 110.755 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.5 -33.05 66.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.753 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 11' ' ' VAL . 58.0 t -77.86 -32.59 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.738 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.21 -32.06 49.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.058 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' C ' ' CD ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -86.48 -34.2 20.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 110.642 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.4 -44.14 66.38 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.667 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 tp -70.18 -41.3 73.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 0.0 110.336 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' HD3' ' OD1' ' A' ' 23' ' ' ASN . 7.7 tpp180 -56.34 -37.88 70.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.286 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.8 -43.36 93.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.229 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -66.32 -11.56 13.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.429 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.638 ' OD1' HG23 ' A' ' 24' ' ' ILE . 0.0 OUTLIER -75.13 -63.75 1.2 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.662 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -59.12 -24.72 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.188 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' N ' HG12 ' A' ' 24' ' ' ILE . . . -83.23 -23.27 32.84 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.566 178.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 -39.07 62.99 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.4 m -75.96 -34.6 59.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.665 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.46 -18.38 52.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.744 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.4 -66.18 0.62 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.353 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.21 -41.27 26.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.449 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 35' ' ' LEU . 55.5 t -63.15 -49.69 82.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.825 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 21.0 t80 -59.93 -13.64 12.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.439 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 66.8 t30 -115.63 -2.77 12.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.355 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 34' ' ' PHE . 5.3 t80 -98.2 -52.65 3.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.84 0.352 . . . . 0.0 111.096 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -106.62 -34.41 7.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER 31.37 76.34 0.38 Allowed Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.293 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' O ' ' N ' ' A' ' 39' ' ' LYS . 88.6 Cg_endo -85.02 -97.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.974 2.449 . . . . 0.0 112.311 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 61.8 -69.77 0.05 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 120.986 0.422 . . . . 0.0 110.502 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -103.48 -9.96 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 39' ' ' LYS . 1.7 ttm180 83.01 78.58 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.952 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 39.67 51.17 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.144 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 2' ' ' LYS . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.82 0.343 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 8.6 mmtt 81.14 21.03 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.987 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -153.45 66.79 5.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.294 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 23.9 Cg_exo -62.92 -22.49 73.86 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.68 2.253 . . . . 0.0 111.882 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.2 mp -43.16 -73.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.196 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -42.79 -27.17 0.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.89 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' O ' HG22 ' A' ' 10' ' ' THR . . . -77.76 -43.47 30.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 5' ' ' ILE . 18.3 tt -74.02 -28.97 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.643 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HD2' ' CG2' ' A' ' 5' ' ' ILE . 2.9 mtpt -77.17 -34.84 56.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.765 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 7' ' ' ALA . 6.0 t -71.57 -30.59 66.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 110.53 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.6 t -78.52 -32.37 16.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.073 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.4 -31.17 76.25 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.739 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -85.49 -24.28 27.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.956 0.408 . . . . 0.0 110.375 179.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.49 -47.31 56.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.31 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.97 -42.96 92.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.871 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -59.48 -28.52 65.04 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.836 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -55.99 5.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.872 0.368 . . . . 0.0 110.474 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.12 -29.88 72.25 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.956 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.2 tp -75.27 -44.75 44.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.966 0.413 . . . . 0.0 110.708 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.501 ' HD2' ' ND2' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -64.39 -37.01 86.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.628 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 24' ' ' ILE . . . -64.43 -37.48 87.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.44 -17.61 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.328 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -70.77 -65.22 0.76 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.065 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -60.53 -18.63 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.04 -24.3 28.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.252 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 m -80.16 -40.33 27.54 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.868 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.902 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -64.35 -43.05 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.736 178.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 27' ' ' THR . . . -50.51 -40.69 52.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.988 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -68.93 -63.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.542 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.08 -36.91 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.099 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 27' ' ' THR . 55.7 t -60.03 -52.7 58.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -54.24 -24.42 18.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.023 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -109.94 7.13 23.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.156 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 2.0 m-30 -101.85 -24.31 14.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.291 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -98.09 48.83 1.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.057 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -136.41 44.18 0.97 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.096 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 36' ' ' LYS . 72.9 Cg_endo -76.86 118.19 4.72 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.742 2.295 . . . . 0.0 112.145 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -77.09 -45.97 25.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.18 27.04 9.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.055 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 44.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -50.08 150.0 2.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.126 -179.98 . . . . . . . . 0 0 . 1 stop_ save_